Role of oxygen and continuous positive airway pressure therapy in chronic obstructive pulmonary disease patients with nocturnal oxygen desaturation
Egyptian Journal of Bronchology volume 10, pages 266–273 (2016)
Sleep has a significant effect on respiration, even in healthy individuals. Breathing difficulties in chronic obstructive pulmonary disease (COPD) patients during sleep are one of the most common symptoms in these patients. Nocturnal desaturation may occur in COPD in the absence of severe daytime hypoxemia. Nocturnal desaturation may contribute to the development of pulmonary hypertension, nocturnal cardiac arrhythmias, and death during sleep. However, the optimal treatment for patients with isolated nocturnal hypoxemia remains uncertain.
Aim of the work
The aim of this study was to assess the role of oxygen and continuous positive airway pressure (CPAP) therapy in COPD patients with nocturnal oxygen desaturation (NOD).
Patients and methods
This study was conducted on 40 male COPD patients. The included patients were classified into two groups: group 1 included normoxic or mildly hypoxic patients with day time SpO2≥91% defined as NOD by fall of greater than 4% from awake SpO2, and group 2 included moderate and severely hypoxic patients with daytime SpO2≤90% who showed a pulse oximetric plot with at least 5 min with SpO2≤90% and a peak of SpO2≤85% and were considered as nocturnal desaturator. The two groups were subjected to full history taking, clinical examination, the Epworth sleepiness scale, anthropometric measurements, pulmonary function tests (spirometry), radiological examination using chest radiograph, and SpO2 using pulse oximetry. SpO2 evaluation using pulse oximetry was carried out for four nights: the first night while breathing room air, the second night while giving low-flow humidified oxygen (2 l/min) overnight, the third night with patients on noninvasive ventilation using autoset CPAP mask, and the fourth night with patients on noninvasive ventilation using autoset CPAP mask with low-flow humidified oxygen (2 l/min).
The included patients had moderate, severe, and very severe COPD according to the GOLD spirometric classification. The highest mean value of oxygen saturation was seen in cases that received CPAP with oxygen, followed by cases that received low-flow humidified nasal oxygen, and the lowest mean value was on CPAP. In group 1, there was no significant difference between mean values of oxygen saturation on oxygen and CPAP, but there was a highly significant difference between mean values of oxygen saturation on oxygen and CPAP with oxygen, as well as on CPAP and CPAP with oxygen. In group 2, there was a significant difference between mean values of oxygen saturation on oxygen and CPAP, on nocturnal oxygen and CPAP with oxygen, as well as on CPAP and CPAP with oxygen.
In group 1, it is better to prescribe nocturnal CPAP with oxygen than nocturnal oxygen alone or nocturnal CPAP alone to COPD patients with NOD in this group, whereas in group 2 it is better to prescribe nocturnal CPAP with oxygen, followed by nocturnal oxygen alone, compared with nocturnal CPAP alone to COPD patients with NOD in this group.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD 2014)
Becker HF, Piper AJ, Flynn WE, McNamara SG, Grunstien RR, Peter JH, Breathing during sleep in patients with nocturnal desaturation. Am J Resp Crit Care Med 1999; 159:112–118.
Hudgel DW, Martin RJ, Capehart M, Johnson B, Hill P. Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease. J Appl Physiol Respir Environ Exerc Physiol 1983; 55:669–677.
Brian DK, Patrcik DM, Walter TM. Hypoxamia in patients with COPD causes, effect and disease progression. Int J Chronic Obstruct Pulm Dis 2011; 6:199–208.
Krachman S, Minai OA, Scharf SM. Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc 2008; 5:536–542.
Highcock M, Shneerson J, Smith I. Increased ventilation with NIPPV does not necessarily improve exercise capacity in COPD. Eur Respir J 2003; 22:100–105.
Fletcher EC, Donner CF, Midgren B, Zielinski J, Levi-Valensi P, Braghiroli A, Survival in COPD patients with a daytime PaO2 greater than 60 mmHg with and without nocturnal oxyhemoglobin desaturation. Chest 1992; 101:649–655.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540–545.
Tiep BL. Long-term home oxygen therapy. Clin Chest Med 1990; 11:505–521.
Agusti A, Hedner J, Marin JM, Barbé F, Cazzola M, Rennard S. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 2011; 20:183–194.
Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest 1994; 105:151–154.
Douglas NJ, Flenley DC. Breathing during sleep in patients with obstructive lung disease. Am Rev Respir Dis 1990; 141(Pt 1):1055–1070.
Millman RP, Kramer NR. Sleep disorders and outpatient treatment of patients with pulmonary disease. Curr Opin Pulm Med 1996; 2:507–512.
McNicholas WT. Impact of sleep in COPD. Chest 2000; 117 (Suppl):48S–53S.
Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC. Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease. Sleep Med 2011; 12:367–372.
Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 2009; 64:133–138.
Kinsman RA, Yaroush RA, Fernandez E, Dirks JF, Schocket M, Fukuhara J Symptoms and experiences in chronic bronchitis and emphysema. Chest 1983; 83:755–761.
Lacasse Y, Sériès F, Vujovic-Zotovic N, Goldstein R, Bourbeau J, Lecours R, Evaluating nocturnal oxygen desaturation in COPD − revised. Respir Med 2011; 105:1331–1337.
De angelis G, Sposato B, Mazzei L, Giocondi F, Sbrocca A, Predictive indexes of nocturnal desaturationin COPD patients not treated with long term oxygen therapy. Eur Rev Med Pharmacol Sci 2001; 5:173–179.
Fleetham JA, Mezon B, West P, Bradley CA, Anthonisen NR, Kryger MH Chemical control of ventilation and sleep arterial oxygen desaturation in patients with COPD. Am Rev Respir Dis 1980; 122:583–589.
Eugene F, Joanna M, George W, Joyce G, Miller T. Nocturnal oxy hemoglobin desaturation in COPD patients with arterial oxygen tensions above 60mm Hg. Chest 1987; 92:604–608.
Zanchet RC, Viegas CA. Nocturnal desaturation: predictors and the effect on sleep patterns in patients with chronic obstructive pulmonary disease and concomitant mild daytime hypoxemia. J Bras Pneumol 2006; 32:207–212.
Bradley TD, Mateika J, Li D, Avendano M, Goldstein RS. Daytime hypercapnia in the development of nocturnal hypoxemia in COPD. Chest 1990; 97:308–312
Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Levi- Valensi P, Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J 1997; 10:1730–1735.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
Mohammad, R.SE., El-Sorougi, W.M., Mohamed, A.S.ED. et al. Role of oxygen and continuous positive airway pressure therapy in chronic obstructive pulmonary disease patients with nocturnal oxygen desaturation. Egypt J Bronchol 10, 266–273 (2016). https://doi.org/10.4103/1687-8426.193637
- chronic obstructive pulmonary disease
- continuous positive airway pressure
- nocturnal oxygen desaturation